BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26547055)

  • 1. Multicomponent assembly of 4-aza-podophyllotoxins: A fast entry to highly selective and potent anti-leukemic agents.
    Jeedimalla N; Flint M; Smith L; Haces A; Minond D; Roche SP
    Eur J Med Chem; 2015 Dec; 106():167-79. PubMed ID: 26547055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward synthesis of third-generation spin-labeled podophyllotoxin derivatives using isocyanide multicomponent reactions.
    Kou L; Wang MJ; Wang LT; Zhao XB; Nan X; Yang L; Liu YQ; Morris-Natschke SL; Lee KH
    Eur J Med Chem; 2014 Mar; 75():282-8. PubMed ID: 24553146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
    Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
    Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cytotoxic activity of novel derivatives of 4'-demethylepipodophyllotoxin.
    Chen SW; Tian X; Tu YQ
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5063-6. PubMed ID: 15380199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and potent cytotoxic activity of novel podophyllotoxin derivatives.
    Li WQ; Wang XL; Qian K; Liu YQ; Wang CY; Yang L; Tian J; Morris-Natschke SL; Zhou XW; Lee KH
    Bioorg Med Chem; 2013 Apr; 21(8):2363-2369. PubMed ID: 23490151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
    Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
    Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
    Kamal A; Suresh P; Mallareddy A; Kumar BA; Reddy PV; Raju P; Tamboli JR; Shaik TB; Jain N; Kalivendi SV
    Bioorg Med Chem; 2011 Apr; 19(7):2349-58. PubMed ID: 21402478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and investigation of antiproliferative and apoptosis-inducing properties of new heterocyclic podophyllotoxin analogues accessible by a one-step multicomponent synthesis.
    Magedov IV; Manpadi M; Slambrouck SV; Steelant WF; Rozhkova E; Przheval'skii NM; Rogelj S; Kornienko A
    J Med Chem; 2007 Oct; 50(21):5183-92. PubMed ID: 17894480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cytotoxic activity on human cancer cells of carbamate derivatives of 4β-(1,2,3-triazol-1-yl)podophyllotoxin.
    Liu JF; Sang CY; Xu XH; Zhang LL; Yang X; Hui L; Zhang JB; Chen SW
    Eur J Med Chem; 2013 Jun; 64():621-8. PubMed ID: 23711769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
    Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
    Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.
    Zhang ZH; Zhang LM; Luo G; Zhang S; Chen H; Zhou J
    J Asian Nat Prod Res; 2014; 16(5):527-34. PubMed ID: 24824554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [4-Aza-2,3-didehydropodophyllotoxins: new lignan with antitumor activity obtained from one-step synthesis].
    Giorgi-Renault S
    Ann Pharm Fr; 2005 Jan; 63(1):63-8. PubMed ID: 15803102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of podophyllotoxin derivatives as selective antitumor agents.
    Wu GR; Xu B; Yang YQ; Zhang XY; Fang K; Ma T; Wang H; Xue NN; Chen M; Guo WB; Jia XH; Wang PL; Lei HM
    Eur J Med Chem; 2018 Jul; 155():183-196. PubMed ID: 29886322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline.
    Shi C; Wang J; Chen H; Shi D
    J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic Agents. 585. Isolation of Bridelia ferruginea Anticancer Podophyllotoxins and Synthesis of 4-Aza-podophyllotoxin Structural Modifications.
    Pettit GR; Searcy JD; Tan R; Cragg GM; Melody N; Knight JC; Chapuis JC
    J Nat Prod; 2016 Mar; 79(3):507-18. PubMed ID: 26938998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in the Application of Podophyllotoxin Derivatives to Fight Against Multidrug-Resistant Cancer Cells.
    Guo Q; Jiang E
    Curr Top Med Chem; 2021; 21(19):1712-1724. PubMed ID: 33441065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A convergent synthesis of alkyne-azide cycloaddition derivatives of 4-α,β-2-propyne podophyllotoxin depicting potent cytotoxic activity.
    Zilla MK; Nayak D; Vishwakarma RA; Sharma PR; Goswami A; Ali A
    Eur J Med Chem; 2014 Apr; 77():47-55. PubMed ID: 24607588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vivo evaluation of polyalkoxy substituted 4H-chromenes and oxa-podophyllotoxins as microtubule destabilizing agents in the phenotypic sea urchin embryo assay.
    Semenova MN; Tsyganov DV; Malyshev OR; Ershov OV; Bardasov IN; Semenov RV; Kiselyov AS; Semenov VV
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3914-8. PubMed ID: 24997684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
    Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
    Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-pot synthesis and biological evaluation of N-(aminosulfonyl)-4-podophyllotoxin carbamates as potential anticancer agents.
    Xu XH; Guan XW; Feng SL; Ma YZ; Chen SW; Hui L
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2890-2894. PubMed ID: 28512026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.